These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7784594)

  • 1. Coronary artery stenosis: detection with contrast-enhanced MR imaging in dogs.
    Saeed M; Wendland MF; Sakuma H; Geschwind JF; Derugin N; Cavagna FM; Higgins CB
    Radiology; 1995 Jul; 196(1):79-84. PubMed ID: 7784594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of the extent of area at risk with fast contrast-enhanced magnetic resonance imaging in experimental coronary artery stenosis.
    Saeed M; Wendland MF; Szolar D; Sakuma H; Geschwind JF; Globits S; Derugin N; Higgins CB
    Am Heart J; 1996 Nov; 132(5):921-32. PubMed ID: 8892762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of myocardial function and perfusion in a canine model of non-occlusive coronary artery stenosis using fast magnetic resonance imaging.
    Schwitter J; Saeed M; Wendland MF; Sakuma H; Bremerich J; Canet E; Higgins CB
    J Magn Reson Imaging; 1999 Jan; 9(1):101-10. PubMed ID: 10030657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI detection of myocardial perfusion changes by gadolinium-DTPA infusion during dipyridamole hyperemia.
    Miller DD; Holmvang G; Gill JB; Dragotakes D; Kantor HL; Okada RD; Brady TJ
    Magn Reson Med; 1989 May; 10(2):246-55. PubMed ID: 2761383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multislice measurement of first-pass transit of gadobenate dimeglumine in normal and ischemic myocardium in dogs.
    Sakuma H; Wendland MF; Saeed M; Derugin N; Geschwind JF; Lauerna K; Mintorovitch J; Cavagna FM; Higgins CB
    Acad Radiol; 1995 Oct; 2(10):864-70. PubMed ID: 9419652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia.
    Wilke N; Simm C; Zhang J; Ellermann J; Ya X; Merkle H; Path G; Lüdemann H; Bache RJ; Uğurbil K
    Magn Reson Med; 1993 Apr; 29(4):485-97. PubMed ID: 8464365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myocardial microcirculation in humans--new approaches using MRI].
    Wacker CM; Bauer WR
    Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of chronic coronary artery disease: value of pharmacologically stressed, dynamically enhanced turbo-fast low-angle shot MR images.
    Klein MA; Collier BD; Hellman RS; Bamrah VS
    AJR Am J Roentgenol; 1993 Aug; 161(2):257-63. PubMed ID: 8333357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.
    Knopp MV; Bourne MW; Sardanelli F; Wasser MN; Bonomo L; Boetes C; Müller-Schimpfle M; Hall-Craggs MA; Hamm B; Orlacchio A; Bartolozzi C; Kessler M; Fischer U; Schneider G; Oudkerk M; Teh WL; Gehl HB; Salerio I; Pirovano G; La Noce A; Kirchin MA; Spinazzi A
    AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model.
    Spuentrup E; Ruhl KM; Botnar RM; Wiethoff AJ; Buhl A; Jacques V; Greenfield MT; Krombach GA; Günther RW; Vangel MG; Caravan P
    Circulation; 2009 Apr; 119(13):1768-75. PubMed ID: 19307474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Prokop M; Schneider G; Vanzulli A; Goyen M; Ruehm SG; Douek P; Daprà M; Pirovano G; Kirchin MA; Spinazzi A
    Radiology; 2005 Feb; 234(2):399-408. PubMed ID: 15616119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of area at risk during coronary occlusion and reperfusion by means of MR perfusion imaging.
    Szolar DH; Saeed M; Wendland M; Sakuma H; Stiskal MA; Derugin N; Higgins CB
    Acta Radiol; 1997 Jul; 38(4 Pt 1):479-88. PubMed ID: 9240664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging.
    Wilke N; Jerosch-Herold M; Wang Y; Huang Y; Christensen BV; Stillman AE; Ugurbil K; McDonald K; Wilson RF
    Radiology; 1997 Aug; 204(2):373-84. PubMed ID: 9240523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
    Pediconi F; Catalano C; Padula S; Roselli A; Dominelli V; Cagioli S; Kirchin MA; Pirovano G; Passariello R
    AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions.
    Pirovano G; Vanzulli A; Marti-Bonmati L; Grazioli L; Manfredi R; Greco A; Holzknecht N; Daldrup-Link HE; Rummeny E; Hamm B; Arneson V; Imperatori L; Kirchin MA; Spinazzi A
    AJR Am J Roentgenol; 2000 Oct; 175(4):1111-20. PubMed ID: 11000175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation.
    Vogl TJ; Stupavsky A; Pegios W; Hammerstingl R; Mack M; Diebold T; Lodemann KP; Neuhaus P; Felix R
    Radiology; 1997 Dec; 205(3):721-8. PubMed ID: 9393527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
    Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
    Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.